5561 related articles for article (PubMed ID: 3717959)
21. Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
Sawada M; Matsui Y; Okudaira Y
Biken J; 1983 Dec; 26(4):169-73. PubMed ID: 6204635
[TBL] [Abstract][Full Text] [Related]
22. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.
Horton HM; Hernandez P; Parker SE; Barnhart KM
Cancer Res; 1999 Aug; 59(16):4064-8. PubMed ID: 10463608
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.
Hubbell HR; Kvalnes-Krick K; Carter WA; Strayer DR
Cancer Res; 1985 Jun; 45(6):2481-6. PubMed ID: 3986788
[TBL] [Abstract][Full Text] [Related]
25. [Basic study on human interferon-beta: Part III. The mechanisms of its antitumor effect].
Kanamori T; Nakamura N; Tobita M; Horisawa Y; Suzuki M; Asami T; Yajima T; Nobuhara M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2111-6. PubMed ID: 2424373
[TBL] [Abstract][Full Text] [Related]
26. [Antitumor effects of human interferon on human tumors heterotransplanted into nude mice].
Sawada M; Oshikane M; Matsui Y; Okudaira Y; Kawashima M; Iwanaga K
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1559-65. PubMed ID: 6182258
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
30. [Antitumor effects of the tumor necrosis factor (PAC-4D) against human gynecological carcinoma transplanted into nude mice].
Suzumori K; Yasui Y; Yagami Y; Kimura K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2341-6. PubMed ID: 3606153
[TBL] [Abstract][Full Text] [Related]
31. [Effect of interferon on mouse glioma].
Nakagawa Y; Suzuki K; Ibayashi N; Ueda S; Hirakawa K; Oku T; Imanishi J; Kishida T
No To Shinkei; 1983 Nov; 35(11):1125-30. PubMed ID: 6197981
[TBL] [Abstract][Full Text] [Related]
32. [Experimental research to clinical application of interferons].
Imamishi J; Tanaka A
Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.
Dooley TP; Stamp-Cole M; Ouding RJ
Lab Anim Sci; 1993 Feb; 43(1):48-57. PubMed ID: 7681492
[TBL] [Abstract][Full Text] [Related]
34. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
Agarwal C; Hembree JR; Rorke EA; Eckert RL
Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114
[TBL] [Abstract][Full Text] [Related]
35. [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis].
Ito Y; Jimbow K; Miura S; Maeda K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1263-8. PubMed ID: 6732253
[TBL] [Abstract][Full Text] [Related]
36. [Clinical trials of human fibroblast interferon (Hu IFN-beta) in the treatment of malignant tumors of the skin].
Ishihara K
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):41-53. PubMed ID: 6345697
[No Abstract] [Full Text] [Related]
37. [Clinical effect and histopathologic observation of malignant melanoma by intratumoral administration of HuIFN- beta].
Ishihara K; Hayasaka K; Yamamoto A
Gan No Rinsho; 1983 May; 29(6):603-7. PubMed ID: 6876428
[TBL] [Abstract][Full Text] [Related]
38. Influence of interferon on C19-steroids in urine of malignant skin melanoma and malignant breast neoplasm patients.
Marković L; Ivanović S; Konstantinović I; Ikić D; Micić J; Stakić B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):416-8. PubMed ID: 6238002
[TBL] [Abstract][Full Text] [Related]
39. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
Pollack VA; Alvarez E; Tse KF; Torgov MY; Xie S; Shenoy SG; MacDougall JR; Arrol S; Zhong H; Gerwien RW; Hahne WF; Senter PD; Jeffers ME; Lichenstein HS; LaRochelle WJ
Cancer Chemother Pharmacol; 2007 Aug; 60(3):423-35. PubMed ID: 17541593
[TBL] [Abstract][Full Text] [Related]
40. Human malignant melanoma heterotransplanted to nude mice.
Tropé C; Johnsson JE; Alm P; Landberg T; Olsson H; Wennerberg J
Neoplasma; 1981; 28(5):585-91. PubMed ID: 7312076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]